Park et al. indicated that surfactin could reduce 12-O-tetradecanoylphorbol-13-acetate (TPA)-mediated breast cancer cell migration/invasion via the inhibition of matrix metallopeptidase-9 (MMP-9) levels 15. The gene discussed is MMP9; the disease is breast cancer.